PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

89 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Addala, A.* et al.: A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: A transatlantic comparison. Diabetes Care 44, 133-140 (2020)
22.
Garvey, W.T.* et al.: Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial. Diabetes Care 43, 1085-1093 (2020)
23.
Kahl, S.* et al.: Empagliflozin effectively lowers liver fat content in well-controlled Type 2 Diabetes: A randomized, double-blind, phase 4, placebo-controlled trial. Diabetes Care 43, 298-305 (2020)
24.
Liu, X.* et al.: Distinct growth phases in early life associated with the risk of type 1 diabetes: The TEDDY study. Diabetes Care 43, 556-562 (2020)
25.
Ochoa-Rosales, C.* et al.: Epigenetic link between statin therapy and type 2 diabetes. Diabetes Care 43, 875-884 (2020)
26.
Soldo, J.* et al.: Increased hepatic ACE2 expression in NAFL and diabetes-A risk for COVID-19 patients? Diabetes Care 43, E134-E136 (2020)
27.
Vehik, K.* et al.: Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the Teddy study. Diabetes Care 43, 2066-2073 (2020)
28.
Dawed, A.Y.* et al.: Variation in the plasma membrane monoamine transporter (PMAT, encoded in SLC29A4) and organic cation transporter 1 (OCT1, encoded in SLC22A1) and gastrointestinal intolerance to metformin in type 2 diabetes: An IMI DIRECT study. Diabetes Care 42, 1027-1033 (2019)
29.
Hulman, A.* et al.: Glucose measurements at various time points during the OGTT and their role in capturing glucose response patterns. Diabetes Care 42, e56-e57 (2019)
30.
Kowall, B.* et al.: Incidence rates of type 2 diabetes in people with impaired fasting glucose (ADA vs. WHO Criteria) and impaired glucose tolerance: Results from an older population (KORA S4/F4/FF4 Study). Diabetes Care 42, E18-E20:DC181473 (2019)
31.
Krischer, J.P.* et al.: Predicting islet cell autoimmunity and type 1 diabetes: An 8-year TEDDY study progress report. Diabetes Care 42, 1051-1060 (2019)
32.
Schlesinger, S.* et al.: General and abdominal obesity and incident distal sensorimotor polyneuropathy: Insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort. Diabetes Care 42, 240-247 (2019)
33.
Winkler, C. et al.: Age, HLA, and sex define a marked risk of organ-specific autoimmunity in first-degree relatives of patients with type 1 diabetes. Diabetes Care 42, 1684-1691 (2019)
34.
Andersen, S.T.* et al.: Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: Addition-Denmark. Diabetes Care 41, 1068-1075 (2018)
35.
Auzanneau, M.* et al.: Area deprivation and regional disparities in treatment and outcome quality of 29,284 pediatric patients with type 1 diabetes in Germany: A cross-sectional multicenter DPV analysis. Diabetes Care 41, 2517-2525 (2018)
36.
Frank-Podlech, S. et al.: Leptin replacement reestablishes brain insulin action in the hypothalamus in congenital leptin deficiency. Diabetes Care 41, 907-910 (2018)
37.
Kähm, K. et al.: Health care costs associated with incident complications in patients with type 2 diabetes in Germany. Diabetes Care 41, 971-978 (2018)
38.
Uusitalo, U.* et al.: Early infant diet and islet autoimmunity in the TEDDY Study. Diabetes Care 41, 522-530 (2018)
39.
Herder, C.* et al.: Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4/FF4 Study. Diabetes Care 40, 569-576 (2017)
40.
TEDDY Study Group (Hummel, S. ; Beyerlein, A. ; Ziegler, A.-G.) et al.: First infant formula type and risk of islet autoimmunity in the environmental determinants of diabetes in the young (TEDDY) study. Diabetes Care 40, 398-404 (2017)